Reuters -- AB Science is preparing for a 50 million euro ($70 million) initial public offering next month in a move that could make it France’s first biotech stock exchange listing since mid-2008.
Reuters -- AB Science is preparing for a 50 million euro ($70 million) initial public offering next month in a move that could make it France’s first biotech stock exchange listing since mid-2008.
